Crossmark

Effectiveness and tolerability of lidocaine 5% spray in the treatment of lifelong premature ejaculation patients: a randomized single-blind placebo-controlled clinical trial

Crossref DOI link: https://doi.org/10.1038/s41443-019-0225-9

Published Online: 2020-01-02

Published Print: 2021-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abu El-Hamd, Mohammed
License Information

Text and Data Mining valid from 2020-01-02

Version of Record valid from 2020-01-02
More Information

Article History

Received: 10 August 2019

Revised: 11 December 2019

Accepted: 17 December 2019

First Online: 2 January 2020

Compliance with ethical standards

:

: The author declares that he has no conflict of interest.

: The current study was reviewed and asserted by the ethical and scientific committee, Faculty of Medicine, Sohag University.

: Informed consents were taken from patients after compete explanations for the possible benefits and side effects from the current clinical trial.This clinical trial was registered on the Clinical Trials.gov website (ExternalRef removed. NCT04062357).

Updates are available Correction dated 2020-01-22

Click to view Correction: https://doi.org/10.1038/s41443-020-0229-5